Skip to main content
. 2008 Nov 4;3(11):e3639. doi: 10.1371/journal.pone.0003639

Table 3. Relative Risk (RR) of Total Incident Cancer and of Site-Specific Cancer by Educational Attainment in Women.

Educational Attainment p-trend a
Less than High School Completed High School Post High School Training Some College College Graduate Post Graduate
All Cancer
Cases, No. 1228 4837 1983 4676 2781 2862
Age Adjusted Rate b 1321.06 1300.76 1311.88 1358.01 1378.40 1394.23
Age Adjusted RR(95%CI) 0.93(0.87,0.99) 0.93(0.89,0.97) 0.94(0.89,0.99) 0.97(0.93,1.02) 0.99(0.94,1.04) 1.00 0.001
Age, Smoking Adjusted RR(95%CI) 0.86(0.80,0.92) 0.89(0.85,0.93) 0.89(0.84,0.94) 0.91(0.87,0.96) 0.96(0.91,1.02) 1.00 <0.001
Multivariate Adjusted RR(95%CI) c 0.84(0.79,0.90) 0.88(0.84,0.92) 0.88(0.83,0.93) 0.91(0.87,0.95) 0.96(0.92,1.02) 1.00 <0.001
Smoking Related Cancer d
Cases, No. 326 1017 401 947 452 403
Age Adjusted Rate b 353.27 270.30 264.98 276.22 229.34 201.12
Age Adjusted RR(95%CI) 1.66(1.43,1.92) 1.35(1.20,1.51) 1.32(1.15,1.51) 1.38(1.23,1.55) 1.13(0.99,1.30) 1.00 <0.001
Age, Smoking Adjusted RR(95%CI) 1.18(1.02,1.37) 1.10(0.98,1.23) 1.03(0.90,1.19) 1.07(0.95,1.20) 1.02(0.89,1.17) 1.00 0.013
Multivariate Adjusted RR(95%CI) 1.19(1.02,1.38) 1.10(0.98,1.24) 1.05(0.91,1.20) 1.07(0.96,1.21) 1.02(0.89,1.17) 1.00 0.012
Head and Neck Cancer
Cases, No. 22 83 35 71 35 30
Age Adjusted Rate b 26.47 22.14 23.14 20.55 17.31 13.87
Age Adjusted RR(95%CI) 1.61(0.92,2.79) 1.54(1.01,2.34) 1.59(0.97,2.59) 1.41(0.92,2.16) 1.18(0.73,1.93) 1.00 0.024
Age, Smoking Adjusted RR(95%CI) 1.08(0.62,1.87) 1.21(0.79,1.83) 1.20(0.74,1.96) 1.07(0.70,1.64) 1.05(0.65,1.71) 1.00 0.505
Multivariate Adjusted RR(95%CI) 1.21(0.69,2.13) 1.33(0.87,2.03) 1.33(0.81,2.17) 1.13(0.74,1.73) 1.07(0.66,1.74) 1.00 0.22
Stomach Cancer
Cases, No. 12 48 16 33 15 20
Age Adjusted Rate b 10.95 12.67 10.58 9.73 7.40 10.71
Age Adjusted RR(95%CI) 1.13(0.55,2.31) 1.21(0.72,2.04) 1.02(0.53,1.97) 0.95(0.54,1.65) 0.76(0.39,1.48) 1.00 0.281
Age, Smoking Adjusted RR(95%CI) 1.05(0.51,2.16) 1.18(0.70,1.99) 1.00(0.52,1.94) 0.91(0.52,1.58) 0.75(0.38,1.46) 1.00 0.372
Multivariate Adjusted RR(95%CI) 0.92(0.44,1.92) 1.14(0.67,1.94) 1.00(0.52,1.94) 0.90(0.52,1.58) 0.75(0.39,1.47) 1.00 0.622
Colon Cancer e
Cases, No. 113 363 164 325 178 139
Age Adjusted Rate b 114.73 95.73 108.15 95.68 90.69 71.20
Age Adjusted RR(95%CI) 1.60(1.24,2.05) 1.35(1.11,1.65) 1.54(1.22,1.93) 1.36(1.11,1.66) 1.29(1.04,1.61) 1.00 <0.001
Age, Smoking Adjusted RR(95%CI) 1.56(1.21,2.00) 1.34(1.10,1.63) 1.50(1.20,1.89) 1.32(1.08,1.61) 1.28(1.03,1.60) 1.00 0.001
Multivariate Adjusted RR(95%CI) 1.37(1.06,1.77) 1.24(1.01,1.51) 1.44(1.14,1.80) 1.28(1.05,1.57) 1.26(1.01,1.58) 1.00 0.029
Rectum Cancer
Cases, No. 34 127 56 116 67 61
Age Adjusted Rate b 34.84 33.81 37.06 33.67 34.40 30.11
Age Adjusted RR(95%CI) 1.16(0.76,1.77) 1.12(0.82,1.52) 1.22(0.85,1.76) 1.12(0.82,1.53) 1.11(0.79,1.57) 1.00 0.447
Age, Smoking Adjusted RR(95%CI) 1.09(0.72,1.67) 1.09(0.80,1.48) 1.18(0.82,1.71) 1.08(0.79,1.48) 1.10(0.78,1.56) 1.00 0.657
Multivariate Adjusted RR(95%CI) 1.05(0.68,1.62) 1.06(0.78,1.45) 1.17(0.81,1.69) 1.08(0.79,1.47) 1.10(0.77,1.55) 1.00 0.822
Pancreatic Cancer
Cases, No. 26 97 44 100 52 61
Age Adjusted Rate b 26.15 25.31 29.01 29.34 26.73 29.85
Age Adjusted RR(95%CI) 0.84(0.53,1.34) 0.83(0.60,1.14) 0.94(0.64,1.39) 0.95(0.69,1.31) 0.86(0.60,1.25) 1.00 0.375
Age, Smoking Adjusted RR(95%CI) 0.76(0.48,1.20) 0.78(0.57,1.08) 0.88(0.60,1.30) 0.88(0.64,1.22) 0.84(0.58,1.21) 1.00 0.168
Multivariate Adjusted RR(95%CI) 0.74(0.47,1.19) 0.79(0.57,1.09) 0.88(0.60,1.30) 0.89(0.64,1.22) 0.84(0.58,1.21) 1.00 0.171
Lung Cancer
Cases, No. 245 687 265 651 298 237
Age Adjusted Rate b 262.84 183.39 175.24 189.69 151.23 119.69
Age Adjusted RR(95%CI) 2.14(1.79,2.56) 1.55(1.34,1.80) 1.49(1.25,1.77) 1.62(1.39,1.87) 1.27(1.07,1.51) 1.00 <0.001
Age, Smoking Adjusted RR(95%CI) 1.43(1.20,1.71) 1.22(1.05,1.41) 1.11(0.93,1.32) 1.19(1.03,1.38) 1.12(0.94,1.33) 1.00 <0.001
Multivariate Adjusted RR(95%CI) 1.43(1.19,1.72) 1.22(1.05,1.42) 1.12(0.94,1.33) 1.20(1.03,1.39) 1.12(0.94,1.33) 1.00 <0.001
Melanomas of the Skin
Cases, No. 25 201 79 200 150 168
Age Adjusted Rate b 26.13 54.02 52.23 57.91 73.65 81.66
Age Adjusted RR(95%CI) 0.33(0.22,0.51) 0.67(0.55,0.82) 0.64(0.49,0.84) 0.71(0.58,0.88) 0.91(0.73,1.13) 1.00 <0.001
Age, Smoking Adjusted RR(95%CI) 0.34(0.23,0.53) 0.69(0.56,0.85) 0.66(0.50,0.86) 0.73(0.59,0.89) 0.92(0.73,1.14) 1.00 <0.001
Multivariate Adjusted RR(95%CI) 0.40(0.26,0.62) 0.71(0.57,0.87) 0.67(0.51,0.88) 0.74(0.60,0.91) 0.93(0.74,1.15) 1.00 <0.001
Bladder Cancer
Cases, No. 26 130 47 110 55 60
Age Adjusted Rate b 27.64 34.25 30.97 32.28 27.91 30.08
Age Adjusted RR(95%CI) 0.85(0.54,1.35) 1.12(0.83,1.53) 1.02(0.70,1.49) 1.07(0.78,1.46) 0.93(0.64,1.33) 1.00 0.886
Age, Smoking Adjusted RR(95%CI) 0.69(0.43,1.10) 1(0.73,1.36) 0.87(0.59,1.28) 0.90(0.65,1.23) 0.86(0.60,1.24) 1.00 0.404
Multivariate Adjusted RR(95%CI) 0.67(0.42,1.07) 0.98(0.72,1.34) 0.86(0.59,1.27) 0.89(0.65,1.23) 0.87(0.60,1.25) 1.00 0.306
Kidney Cancer
Cases, No. 41 98 39 93 36 52
Age Adjusted Rate b 41.70 26.22 25.95 27.20 17.41 25.78
Age Adjusted RR(95%CI) 1.68(1.12,2.54) 1.03(0.73,1.44) 1.01(0.67,1.53) 1.06(0.75,1.49) 0.70(0.46,1.07) 1.00 0.006
Age, Smoking Adjusted RR(95%CI) 1.61(1.07,2.44) 1.01(0.72,1.42) 0.98(0.65,1.49) 1.02(0.72,1.43) 0.69(0.45,1.06) 1.00 0.011
Multivariate Adjusted RR(95%CI) 1.29(0.85,1.98) 0.89(0.63,1.25) 0.87(0.58,1.33) 0.95(0.67,1.33) 0.69(0.45,1.06) 1.00 0.179
Thyroid Cancer
Cases, No. 11 62 15 50 30 25
Age Adjusted Rate b 11.86 16.81 9.80 14.38 14.43 11.87
Age Adjusted RR(95%CI) 1.03(0.51,2.10) 1.44(0.90,2.29) 0.84(0.44,1.59) 1.21(0.75,1.96) 1.22(0.72,2.08) 1.00 0.542
Age, Smoking Adjusted RR(95%CI) 1.07(0.52,2.18) 1.50(0.94,2.39) 0.87(0.46,1.66) 1.24(0.77,2.01) 1.24(0.73,2.11) 1.00 0.435
Multivariate Adjusted RR(95%CI) 1.01(0.49,2.08) 1.45(0.90,2.33) 0.86(0.45,1.63) 1.23(0.76,1.99) 1.26(0.74,2.14) 1.00 0.609
Lymphoma
Cases, No. 64 236 87 213 121 128
Age Adjusted Rate b 71.15 61.72 57.25 62.25 61.34 62.77
Age Adjusted RR(95%CI) 1.04(0.77,1.40) 0.99(0.80,1.23) 0.91(0.69,1.19) 0.98(0.79,1.22) 0.96(0.75,1.23) 1.00 0.855
Age, Smoking Adjusted RR(95%CI) 1.01(0.75,1.37) 0.98(0.79,1.21) 0.90(0.68,1.18) 0.97(0.78,1.21) 0.95(0.74,1.22) 1.00 0.988
Multivariate Adjusted RR(95%CI) 0.99(0.72,1.34) 0.94(0.76,1.18) 0.88(0.67,1.15) 0.96(0.77,1.20) 0.95(0.74,1.22) 1.00 0.772
Leukemia
Cases, No. 24 77 38 68 31 40
Age Adjusted Rate b 22.06 20.60 25.12 19.73 15.66 19.75 0.162
Age Adjusted RR(95%CI) 1.27(0.76,2.11) 1.04(0.71,1.53) 1.27(0.82,1.99) 1.01(0.68,1.49) 0.79(0.49,1.26) 1.00 0.169
Age, Smoking Adjusted RR(95%CI) 1.27(0.76,2.11) 1.04(0.71,1.53) 1.26(0.81,1.97) 1.00(0.67,1.47) 0.78(0.49,1.25) 1.00 0.401
Multivariate Adjusted RR(95%CI) 1.14(0.68,1.93) 0.97(0.66,1.43) 1.19(0.76,1.85) 0.96(0.65,1.42) 0.78(0.49,1.26) 1.00
Invasive Breast Cancer e
Cases, No. 202 876 372 924 574 626
Age Adjusted Rate b 332.68 383.29 400.06 434.73 462.79 482.76
Age Adjusted RR(95%CI) 0.72(0.61,0.84) 0.79(0.71,0.87) 0.81(0.72,0.93) 0.88(0.80,0.98) 0.93(0.83,1.04) 1.00 <0.001
Age, Smoking Adjusted RR(95%CI) 0.70(0.60,0.82) 0.78(0.70,0.86) 0.80(0.71,0.91) 0.87(0.78,0.96) 0.93(0.83,1.04) 1.00 <0.001
Multivariate Adjusted RR(95%CI) 0.83(0.70,0.98) 0.87(0.78,0.97) 0.88(0.77,1.00) 0.93(0.84,1.04) 0.98(0.87,1.10) 1.00 0.002
Cervical Cancer
Cases, No. 11 32 11 30 13 15
Age Adjusted Rate b 13.96 8.91 7.36 8.51 6.51 7.19
Age Adjusted RR(95%CI) 1.85(0.84,4.04) 1.29(0.70,2.40) 1.05(0.48,2.30) 1.23(0.66,2.29) 0.89(0.42,1.87) 1.00 0.083
Age, Smoking Adjusted RR(95%CI) 1.63(0.74,3.57) 1.19(0.64,2.21) 0.95(0.44,2.08) 1.12(0.60,2.09) 0.85(0.41,1.79) 1.00 0.163
Multivariate Adjusted RR(95%CI) 1.20(0.52,2.74) 0.95(0.49,1.83) 0.86(0.39,1.93) 1.04(0.54,1.98) 0.82(0.38,1.75) 1.00 0.646
Endometrial Cancer f
Cases, No. 65 307 117 285 194 215
Age Adjusted Rate b 72.72 82.71 77.52 82.55 94.16 103.78
Age Adjusted RR(95%CI) 0.67(0.51,0.89) 0.80(0.67,0.96) 0.75(0.60,0.93) 0.79(0.66,0.95) 0.92(0.76,1.11) 1.00 0.001
Age, Smoking Adjusted RR(95%CI) 0.72(0.54,0.95) 0.83(0.69,0.98) 0.77(0.62,0.97) 0.82(0.69,0.98) 0.93(0.77,1.13) 1.00 0.003
Multivariate Adjusted RR(95%CI) 0.65(0.49,0.87) 0.77(0.65,0.93) 0.75(0.60,0.95) 0.85(0.71,1.02) 0.99(0.82,1.21) 1.00 <0.001
Ovarian Cancer e , g
Cases, No. 32 123 53 125 98 73
Age Adjusted Rate b 37.19 32.72 35.14 36.07 48.77 35.08
Age Adjusted RR(95%CI) 0.96(0.64,1.46) 0.94(0.70,1.25) 0.99(0.69,1.41) 1.02(0.77,1.36) 1.36(1.01,1.85) 1.00 0.175
Age, Smoking Adjusted RR(95%CI) 0.98(0.65,1.49) 0.94(0.70,1.26) 1.00(0.70,1.42) 1.03(0.77,1.38) 1.37(1.01,1.86) 1.00 0.202
Multivariate Adjusted RR(95%CI) 1.08(0.70,1.67) 1.00(0.74,1.36) 1.07(0.75,1.54) 1.11(0.83,1.49) 1.43(1.05,1.94) 1.00 0.476

Abbreviations: RR, relative risk; CI, confidence interval; BMI, body mass index (calculated as weight kilograms divided by height in meters squared); MHT, menopausal hormone therapy.

a

p for trend across education groups.

b

Age-adjusted Incidence rates are per 100,000 person-years by 5 year age intervals.

c

Multivariate models included the following covariates: age (yrs); race (White, Black, Hispanic and Asian, Pacific Islanders and Native Americans, combined); smoking (Never, Quit < = 1 pack per day, Quit>1 pack per day, Currently smoking < = 1 pack per day, Currently Smoking>1 pack per day); alcohol consumptions g/day (0; 0.1−<5, 5 −<15, 15<30, 30+); energy (Kcal/day);BMI (<25, 25−<30, 30−<35, 35+); Physical activity (Frequency of at least 20 minutes that caused increases in breathing or heart rate, or worked up a sweat: Never/Rarely, 1–3 time per month, 1–2 times per week, 3–4 times per week, 5+ times per week, Unknown), married (yes/no); family history of cancer (yes/no); MHT use (Current, Former, Never). In female specific anatomical sites, a combined variable of age at first birth and number of children was included.

d

Smoking related cancers include sites: head neck, esophageal, lung, pancreas, bladder.

e

For the sites of colon, breast and ovarian models were adjusted for screening behavior.

f

Women who reported a hysterectomy were excluded from the statistical models for endometrial cancer.

g

Women with both ovaries removed were excluded from the statistical models for ovarian cancer.